The government has launched Production Linked Incentive (PLI) schemes for 14 key sectors with the aim of boosting domestic manufacturing, attracting private investment, increasing exports, and generating employment, with an approved budget of ₹1.91 lakh crore. While the Department for Promotion of Industry and Internal Trade (DPIIT) oversees overall coordination, individual ministries are responsible for implementing the schemes related to their respective sectors.
According to the government, India’s Production Linked Incentive (PLI) schemes have attracted investments exceeding ₹2.40 lakh crore and generated over 14.15 lakh direct and indirect jobs by March 31, 2026. These schemes have also resulted in exports worth more than ₹15.2 lakh crore, highlighting their growing role in strengthening India’s manufacturing sector and global competitiveness.
In the pharmaceutical sector, total sales under this scheme have exceeded ₹3.64 lakh crore. Meanwhile, the bulk drugs initiative has created a manufacturing capacity of approximately 55,000 metric tonnes for 26 essential Active Pharmaceutical Ingredients (APIs), helping to reduce import dependency. The medical device scheme has also boosted the domestic production of advanced equipment, including CT scanners, MRI systems, cath labs, and ultrasonography machines.
The government has stated that the electronics sector has emerged as one of the biggest beneficiaries of this scheme, mobile phone production has increased nearly 2.4 times since the scheme’s inception. Mobile phone imports have dropped by approximately 77%, while 99.2% of the phones used in India are now manufactured domestically.
According to the government, the PLI schemes are reviewed regularly by the Empowered Group of Secretaries (EGoS) and the concerned ministries. Based on feedback from the industry, modifications have been made to the eligibility criteria and implementation guidelines to enhance participation, accelerate investment, and strengthen India’s manufacturing ecosystem.
(PIB)
